Published in Neurology on February 13, 2001
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl (2013) 1.88
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation (2005) 1.66
Physical Activity and Risk of Coronary Heart Disease and Stroke in Older Adults: The Cardiovascular Health Study. Circulation (2015) 1.56
Determining stroke's rank as a cause of death using multicause mortality data. Stroke (2012) 1.53
Slower gait, slower information processing and smaller prefrontal area in older adults. Age Ageing (2011) 1.42
Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med (2005) 1.35
Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol (2010) 1.26
Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study. Stroke (2011) 1.18
Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol (2001) 1.10
Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort. Stroke (2008) 1.09
Neighborhood disadvantage and ischemic stroke: the Cardiovascular Health Study (CHS). Stroke (2011) 1.07
The effects of chronic cigarette smoking on gray matter volume: influence of sex. PLoS One (2014) 1.02
Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc (2006) 1.01
Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology (2010) 1.00
Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke (2015) 1.00
Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J Clin Endocrinol Metab (2012) 0.98
Intravenous tissue plasminogen activator and stroke in the elderly. Am J Emerg Med (2010) 0.98
Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Am J Hypertens (2013) 0.97
Gene variants associated with ischemic stroke: the cardiovascular health study. Stroke (2008) 0.95
Mexican Americans with atrial fibrillation have more recurrent strokes than do non-Hispanic whites. Stroke (2010) 0.94
Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma. World J Surg (2012) 0.94
Risk of intraparenchymal hemorrhage with magnetic resonance imaging-defined leukoaraiosis and brain infarcts. Ann Neurol (2012) 0.94
Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults. Stroke (2011) 0.93
Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study. Circulation (2015) 0.90
Progression of magnetic resonance imaging-defined brain vascular disease predicts vascular events in elderly: the Cardiovascular Health Study. Stroke (2011) 0.85
The disability burden associated with stroke emerges before stroke onset and differentially affects blacks: results from the health and retirement study cohort. J Gerontol A Biol Sci Med Sci (2014) 0.85
Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health Study. J Thromb Haemost (2011) 0.84
Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study. J Clin Endocrinol Metab (2014) 0.83
Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults. Atherosclerosis (2014) 0.82
Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts. Circulation (2013) 0.82
Carotid intima-media thickness, electrocardiographic left ventricular hypertrophy, and incidence of intracerebral hemorrhage. Stroke (2011) 0.81
Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study. Clin Endocrinol (Oxf) (2014) 0.81
Novel circulating fatty acid patterns and risk of cardiovascular disease: the Cardiovascular Health Study. Am J Clin Nutr (2012) 0.81
CHA(2)DS(2)-VASc score and prognosis in ischemic strokes with atrial fibrillation. J Neurol (2011) 0.79
Physical Activity, Physical Fitness, and Leukocyte Telomere Length: The Cardiovascular Health Study. Med Sci Sports Exerc (2015) 0.79
Height and risk of incident intraparenchymal hemorrhage: Atherosclerosis Risk in Communities and Cardiovascular Health study cohorts. J Stroke Cerebrovasc Dis (2011) 0.78
Incident Atrial Fibrillation and Disability-Free Survival in the Cardiovascular Health Study. J Am Geriatr Soc (2016) 0.77
Associations of NINJ2 sequence variants with incident ischemic stroke in the Cohorts for Heart and Aging in Genomic Epidemiology (CHARGE) consortium. PLoS One (2014) 0.77
The Perioperative Management of Antithrombotic Therapies Using Enoxaparin. J Korean Med Sci (2017) 0.75
Changes in Depressive Symptoms and Subsequent Risk of Stroke in the Cardiovascular Health Study. Stroke (2016) 0.75
Major vessel occlusion may predict subtherapeutic anticoagulation intensity and feasibility of administration of intravenous thrombolytics. PLoS One (2017) 0.75
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia. Cerebrovasc Dis Extra (2017) 0.75
Factors Associated With Ischemic Stroke Survival and Recovery in Older Adults. Stroke (2017) 0.75
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Incidence of and risk factors for atrial fibrillation in older adults. Circulation (1997) 8.18
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
DISTRIBUTION OF ASCORBIC ACID IN THE BLOOD AND ITS NUTRITIONAL SIGNIFICANCE. J Clin Invest (1940) 6.38
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol (2000) 4.16
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol (1999) 3.36
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet (1996) 3.28
Time to act on drug safety. JAMA (1998) 3.22
Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J (2001) 3.22
Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med (1997) 3.05
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation (2000) 2.96
Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001) 2.93
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation (1998) 2.83
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity. BMJ (1999) 2.83
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77
Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol (1998) 2.77
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation (2000) 2.71
Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71
Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol (2001) 2.68
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Natural statins and stroke risk. Circulation (1999) 2.55
Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke (1996) 2.48
Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation (1998) 2.47
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis (2001) 2.40
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet (2003) 2.37
Potential problems with random zero sphygmomanometer. Lancet (1990) 2.31
Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ (1989) 2.27
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21
Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum (1998) 2.19
Treatment of hypertensive patients with diabetes. Lancet (1998) 2.16
Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis. J Thromb Haemost (2013) 2.13
Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial. Stroke (1996) 2.10
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. Hypertension (1991) 2.04
Trends in pharmacologic management of hypertension in the United States. Arch Intern Med (1995) 2.04
Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med (2001) 2.01
Assessment of quality of life in clinical trials of cardiovascular therapies. Am J Cardiol (1984) 1.99
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J (2002) 1.98
Visualization and temporal/spatial characterization of cardiac radiofrequency ablation lesions using magnetic resonance imaging. Circulation (2000) 1.96
Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol (1997) 1.90
Surgical bleeding: unexpected effect of a calcium antagonist. BMJ (1995) 1.88
The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens (2010) 1.86
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med (1984) 1.82
Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet (1999) 1.73
Secondary prevention after myocardial infarction: a review of long-term trials. Prog Cardiovasc Dis (1982) 1.71
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost (2004) 1.70
Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison. Mol Pharmacol (1998) 1.69
Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation (2001) 1.68
Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol (1999) 1.66
Lessons learned from a prospective meta-analysis. J Am Geriatr Soc (1995) 1.65
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost (2006) 1.62
Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA (1993) 1.60
Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol (1985) 1.60
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost (2007) 1.59
Developing an optimal approach to global drug safety. J Intern Med (2001) 1.57
Dietary preference for sweet foods in patients with dementia. J Am Geriatr Soc (1990) 1.57
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol (2001) 1.56
Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events. Lancet (1997) 1.56
Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension (1992) 1.53
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation (2000) 1.51
Factors associated with healthy aging: the cardiovascular health study. J Am Geriatr Soc (2001) 1.51
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer (1997) 1.50
Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology (2011) 1.49
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48
Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost (2006) 1.46
Accurate diagnosis of convulsive syncope: role of an implantable subcutaneous ECG monitor. Seizure (1999) 1.44
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) Am J Cardiol (1995) 1.43
Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. J Neurol Neurosurg Psychiatry (2009) 1.43
[Scleroderma and pregnancy: obstetrical complications and the impact of pregnancy on the course of the disease]. Med Clin (Barc) (1999) 1.39
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer (2005) 1.39
Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med (1999) 1.39
Effect of propranolol in postinfarction patients with mechanical or electrical complications. Circulation (1984) 1.38
[Calcium antagonists: safe or unsafe?]. Ned Tijdschr Geneeskd (1996) 1.38
Utility of new electrocardiographic models for left ventricular mass in older adults. The Cardiovascular Health Study Collaborative Research Group. Hypertension (1996) 1.37
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis (1998) 1.37
Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med (1999) 1.33